Tianyin Pharmaceutical Inc Co  

(Public, NYSEMKT:TPI)   Watch this stock  
Find more results for TPI
0.610
+0.010 (1.67%)
Jul 29 - Close
NYSEMKT real-time data - Disclaimer
Currency in USD
Range 0.60 - 0.62
52 week 0.54 - 1.44
Open 0.61
Vol / Avg. 22,478.00/58,968.00
Mkt cap 17.95M
P/E 3.39
Div/yield     -
EPS 0.18
Shares 29.43M
Beta 1.49
Inst. own 11%

Key stats and ratios

Q1 (Mar '14) 2013
Net profit margin -0.10% 9.80%
Operating margin 4.70% 13.80%
EBITD margin - 17.41%
Return on average assets -0.03% 6.17%
Return on average equity 0.15% 7.13%
Employees 1,200 -
CDP Score - -

Address

23rd Floor, Unionsun Yangkuo Plaza, No. 2, 3rd block, South Renmin Road
CHENGDU, SIC 610041
China
+86-28-82002232 (Phone)
+86-28-85516676 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company�s indirect wholly owned subsidiary Chengdu Tianyin Pharmaceutical Co., Ltd. (Chengdu Tianyin), it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in the People�s Republic of China. It is manufacturing a range of 56 products, 23 of which are listed in the highly selective National Medical Reimbursement List (NMRL) and seven are listed in the Essential Drug List (EDL) of the People�s Republic of China.

Officers and directors

Guoqing Jiang Chairman of the Board, President, Chief Executive Officer
Age: 46
Bio & Compensation  - Reuters
Jiayuan Tong M.D., Ph.D. Chief Financial Officer, Chief Business & Development Officer, Director
Age: 39
Bio & Compensation  - Reuters
Tao Yang Chief Operating Officer
Age: 45
Bio & Compensation  - Reuters
Jianping Hou Ph.D. Independent Director
Age: 52
Bio & Compensation  - Reuters
Bo Tan Independent Director
Age: 39
Bio & Compensation  - Reuters
Zunjian Zhang Ph.D. Independent Director
Age: 53
Bio & Compensation  - Reuters